Loading...

Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy

BACKGROUND: Current treatment options for stage III non-small cell lung cancer (NSCLC) consist of different combinations of chemotherapy, surgery, radiotherapy and immunotherapy. Treatment choices are highly individual decisions, in which adverse events (AEs) are relevant for decision-making. This s...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:ERJ Open Res
Main Authors: Iseli, Thomas, Berghmans, Thierry, Glatzer, Markus, Rittmeyer, Achim, Massard, Gilbert, Durieux, Valérie, Buchsbaum, Thomas, Putora, Paul Martin
Format: Artigo
Sprog:Inglês
Udgivet: European Respiratory Society 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7487347/
https://ncbi.nlm.nih.gov/pubmed/32963993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00010-2020
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!